
A reported funding round would deepen ties between the chipmaker and a fast-growing compute supplier.
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

A reported funding round would deepen ties between the chipmaker and a fast-growing compute supplier.

History implores investors not to miss the forest for the trees.

High-yielding dividend stocks are highly sensitive to changes in interest rates.

Even after a more than tenfold rise in the past five years, it's valid to argue that this AI stock is cheap.

The latest quarterly report from Victoria's Secret actually looked pretty strong, but its stock still lost ground.

Even after a double-digit sell-off this week, Palo Alto stock is still up more than 80% in 2026.

Rezolve's revenue grew nearly 2,000% annually in this year's first half, but investors have questions about the business's outlook.
Hugging Face spent years doing everything a company does before going public. It hit $150 million in annualized revenue, attracted 18 million developers to its platform, and netted almost $395 million from backers like Amazon, Intel, Sequoia and Coatue. Then Nvidia made it an offer it couldn’t refuse. On Thursday, the chipmaker confirmed a deal to acquire the AI model distribution platform for $12.9 billion. The IPO has always been the destination for venture-backed companies. Before the late 20

Berkshire Hathaway's relatively new CEO has already handled the integration of two purchases.

The Federal Reserve recently warned investors that the S&P 500's equity risk premium was near its lowest level in decades.

Trump just opined that U.S. gross domestic product (GDP) can grow by “20%” if the Federal Reserve slashed interest rates.

Home Depot's combination of potential upside and dividends make the stock attractive.

Payroll gains of 162,000 in August may alter what the Fed does in the coming months.

The chipmaker's up-to-$5 billion pledge comes with conditions attached -- and the company on the receiving end is about to get a public price.

Both companies are delivering impressive revenue growth.

These companies have already recorded billions in profits from their Anthropic stakes.

Jerome Powell’s successor has flipped the script on inflation.

Gilead Sciences is branching out beyond its HIV franchise into oncology and immunology therapies.

Unrealized gains are lovely when they happen, but they can also turn into unrealized losses.

History shows that this ETF should be a great long-term investment, regardless of any short-term noise.

Despite a solid quarter, the market seems skeptical about the fintech's future.

Thiel is known for his ability to spot a future winner.

TAIPEI, Sept 5 (Reuters) - Foxconn's third-quarter performance is expected to outperform market expectations given strong AI-related demand, the Taiwanese contract electronics maker said on Saturday,

Negotiators offered access to advanced AI hardware to help secure a preliminary agreement last year to end decades of conflict, the latest example of chip diplomacy.

The much-anticipated launch led to a share price plunge.

Some investors worry that the pace of artificial intelligence (AI) infrastructure build-outs is not sustainable.

Oura has expanded to really become a health analytics company.

August payrolls came in three times hotter than expected. Stocks barely flinched. What's going on?

Nscale, a cloud computing firm focused on artificial intelligence, is in talks with potential investors to raise as much as $3.5 billion in financing ahead of a planned initial public offering, according to people familiar with the matter.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.